our executive leadership

 

contact Marc via e-mail   contact Marc via linkedIn   view video

Marc Limacher

Founder & CEO

Marc Limacher started INOVIS in 1992 as a boutique primary CI specialty firm in Palo Alto, CA, specializing in the pharma/biotech and IT industries.

A 26-year veteran in the CI and counter-intelligence industry, Marc has grown INOVIS into a global leader in primary intelligence & strategic consulting services, serving a select group of loyal, global Fortune 100 companies as loyal clients. He is responsible for the overall strategic direction of the firm and manages the operation of the IT/telco practice.

Prior to INOVIS, Marc was Director of Market Intelligence at a leading U.S. institutional investment firm for five years, providing primary intelligence on small-/medium-/large-cap life science equities via a global employee network of 125 investigative journalists. He also delivers private CI seminars and is a frequent lecturer on CI and counter-intelligence topics at companies and to academia.

Marc is fluent in 5 languages and enjoys proximity to the ski slopes from the Lucerne office, to the Pacific waves from the Palo Alto office, and to NYC from the Princeton office

contact Marc via e-mail  marc@inovis.global
 

contact Marc via linkedIn  visit Marc at LinkedIn
 

view video  view an interview with Marc
 

contact Baljit via e-mail   contact Baljit via linkedIn   view video

Baljit Singh

Managing Director and Partner, Global Pharmaceuticals & Life Sciences Division

Dr. Baljit Singh, Managing Director of INOVIS Life Sciences, has more than 10 years of experience in the global pharmaceutical, biotech, and generics market. He is based in Lucerne at INOVIS’ Global Headquarters in Switzerland, where his key responsibilities include both running day-today operational activities and shaping near- and long-term strategic business direction

He joined INOVIS from Novartis Pharma AG, where he most recently served as Global Director of Integrated Insights, helping develop competitive intelligence (CI) functions and processes that are still in effect today. Prior to this, he managed Global Competitive Intelligence for Respiratory and Primary Care at Novartis.

Previously, Dr. Singh headed Competitive Intelligence for a major Generics and Biosimilar intelligence firm, helping pharmaceutical clients optimize their lifecycle strategies.

Dr. Singh studied pharmacy at the Royal Danish School of Pharmacy in Copenhagen, Denmark and received his Ph.D in Pharmaceutics from London School of Pharmacy. He has played cricket for the Danish National team for ~10 Years.

contact Baljit via e-mail  baljit@inovis.global
 

contact Baljit via linkedIn  visit Baljit at LinkedIn
 

Copyright © 2018 INOVIS